Correlation Between KING PHARMACEUTICALS and RB Global

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both KING PHARMACEUTICALS and RB Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KING PHARMACEUTICALS and RB Global into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KING PHARMACEUTICALS INC and RB Global, you can compare the effects of market volatilities on KING PHARMACEUTICALS and RB Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KING PHARMACEUTICALS with a short position of RB Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of KING PHARMACEUTICALS and RB Global.

Diversification Opportunities for KING PHARMACEUTICALS and RB Global

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between KING and RBA is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding KING PHARMACEUTICALS INC and RB Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RB Global and KING PHARMACEUTICALS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KING PHARMACEUTICALS INC are associated (or correlated) with RB Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RB Global has no effect on the direction of KING PHARMACEUTICALS i.e., KING PHARMACEUTICALS and RB Global go up and down completely randomly.

Pair Corralation between KING PHARMACEUTICALS and RB Global

Allowing for the 90-day total investment horizon KING PHARMACEUTICALS INC is expected to under-perform the RB Global. In addition to that, KING PHARMACEUTICALS is 2.01 times more volatile than RB Global. It trades about -0.16 of its total potential returns per unit of risk. RB Global is currently generating about -0.1 per unit of volatility. If you would invest  10,929  in RB Global on August 5, 2025 and sell it today you would lose (1,007) from holding RB Global or give up 9.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

KING PHARMACEUTICALS INC  vs.  RB Global

 Performance 
       Timeline  
KING PHARMACEUTICALS INC 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days KING PHARMACEUTICALS INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
RB Global 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days RB Global has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

KING PHARMACEUTICALS and RB Global Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with KING PHARMACEUTICALS and RB Global

The main advantage of trading using opposite KING PHARMACEUTICALS and RB Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KING PHARMACEUTICALS position performs unexpectedly, RB Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RB Global will offset losses from the drop in RB Global's long position.
The idea behind KING PHARMACEUTICALS INC and RB Global pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency